Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1982 Feb;41(1):59–65. doi: 10.1136/ard.41.1.59

Allopurinol treatment and its effect on renal function in gout: a controlled study.

T Gibson, V Rodgers, C Potter, H A Simmonds
PMCID: PMC1000865  PMID: 7039523

Abstract

Fifty-nine patients with primary gout were treated with either a combination of colchicine and allopurinol or colchicine alone. Assessments of renal function over 2 years revealed a statistically significant fall of glomerular filtration rate an urine concentrating ability in those receiving only colchicine. The renal function of patients given allopurinol did not change. Treatment with allopurinol resulted ina significant reduction of ammonium excretion, a phenomenon which could not be readily explained. Urate clearance also declined during allopurinol treatment, and the impaired urate clearance associated with gout became more evident. The most important observation was that allopurinol retarded an apparent decline of renal function. Presumably this was achieved through its hypouricaemic effect and implies that the hyperuricaemia of gouty patients is deleterious to the kidneys.

Full text

PDF
64

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROWN J., MALLORY G. K. Renal changes in gout. N Engl J Med. 1950 Aug 31;243(9):325–329. doi: 10.1056/NEJM195008312430901. [DOI] [PubMed] [Google Scholar]
  2. Barlow K. A., Beilin L. J. Renal disease in primary gout. Q J Med. 1968 Jan;37(145):79–96. [PubMed] [Google Scholar]
  3. Briney W. G., Ogden D., Bartholomew B., Smyth C. J. The influence of allopurinol on renal function in gout. Arthritis Rheum. 1975 Nov-Dec;18(6 Suppl):877–881. doi: 10.1002/art.1780180735. [DOI] [PubMed] [Google Scholar]
  4. Cameron J. S. Uric acid and the kidney. Proc R Soc Med. 1973 Sep;66(9):900–902. [PMC free article] [PubMed] [Google Scholar]
  5. Chan J. C. The rapid determination of urinary titratable acid and ammonium and evaluation of freezing as a method of preservation. Clin Biochem. 1972 Jun;5(2):94–98. doi: 10.1016/s0009-9120(72)80014-6. [DOI] [PubMed] [Google Scholar]
  6. Coombs F. S., Pecora L. J., Thorogood E., Consolazio W. V., Talbott J. H. RENAL FUNCTION IN PATIENTS WITH GOUT. J Clin Invest. 1940 May;19(3):525–535. doi: 10.1172/JCI101156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Emmerson B. T. Gout, uric acid and renal disease. Med J Aust. 1976 Mar 20;1(12):403–405. doi: 10.5694/j.1326-5377.1976.tb140703.x. [DOI] [PubMed] [Google Scholar]
  8. Fessel W. J. Renal outcomes of gout and hyperuricemia. Am J Med. 1979 Jul;67(1):74–82. doi: 10.1016/0002-9343(79)90076-7. [DOI] [PubMed] [Google Scholar]
  9. GONICK H. C., RUBINI M. E., GLEASON I. O., SOMMERS S. C. THE RENAL LESION IN GOUT. Ann Intern Med. 1965 Apr;62:667–674. doi: 10.7326/0003-4819-62-4-667. [DOI] [PubMed] [Google Scholar]
  10. Garnett E. S., Parsons V., Veall N. Measurement of glomerular filtration-rate in man using a 51Cr-edetic-acid complex. Lancet. 1967 Apr 15;1(7494):818–819. doi: 10.1016/s0140-6736(67)92781-x. [DOI] [PubMed] [Google Scholar]
  11. Gibson T., Highton J., Potter C., Simmonds H. A. Renal impairment and gout. Ann Rheum Dis. 1980 Oct;39(5):417–423. doi: 10.1136/ard.39.5.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gibson T., Kilbourn K., Horner I., Simmonds H. A. Mechanism and treatment of hypertriglyceridaemia in gout. Ann Rheum Dis. 1979 Feb;38(1):31–35. doi: 10.1136/ard.38.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Grahame R., Scott J. T. Clinical survey of 354 patients with gout. Ann Rheum Dis. 1970 Sep;29(5):461–468. doi: 10.1136/ard.29.5.461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gutman A. B. The past four decades of progress in the knowledge of gout, with an assessment of the present status. Arthritis Rheum. 1973 Jul-Aug;16(4):431–445. doi: 10.1002/art.1780160402. [DOI] [PubMed] [Google Scholar]
  15. Gutman A. B., Yü T. F., Berger L. Renal function in gout. 3. Estimation of tubular secretion and reabsorption of uric acid by use of pyrazinamide (pyrazinoic acid). Am J Med. 1969 Oct;47(4):575–592. doi: 10.1016/0002-9343(69)90188-0. [DOI] [PubMed] [Google Scholar]
  16. Hollingworth P., Reardon J. A., Scott J. T. Acute gout during hypouricaemic therapy: prophylaxis with colchicine. Ann Rheum Dis. 1980 Oct;39(5):529–529. doi: 10.1136/ard.39.5.529-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Klinenberg J. R. Hyperuricemia and gout. Med Clin North Am. 1977 Mar;61(2):299–312. doi: 10.1016/s0025-7125(16)31334-7. [DOI] [PubMed] [Google Scholar]
  18. Klinenberg J. R., Kippen I., Bluestone R. Hyperuricemic nephropathy: pathologic features and factors influencing urate deposition. Nephron. 1975;14(1):88–98. doi: 10.1159/000180438. [DOI] [PubMed] [Google Scholar]
  19. Plante G. E., Durivage J., Lemieux G. Renal excretion of hydrogen in primarygout. Metabolism. 1968 Apr;17(4):377–385. doi: 10.1016/0026-0495(68)90108-x. [DOI] [PubMed] [Google Scholar]
  20. Rosenfeld J. B. Effect of long-term allopurinol administration on serial GFR in normotensive and hypertensive hyperuricemic subjects. Adv Exp Med Biol. 1974;41:581–596. doi: 10.1007/978-1-4757-1433-3_28. [DOI] [PubMed] [Google Scholar]
  21. SEARCY R. L., BERGQUIST L. M. A new color reaction for the quantitation of serum cholesterol. Clin Chim Acta. 1960 Mar;5:192–199. doi: 10.1016/0009-8981(60)90035-8. [DOI] [PubMed] [Google Scholar]
  22. SOKOLOFF L. The pathology of gout. Metabolism. 1957 May;6(3):230–243. [PubMed] [Google Scholar]
  23. Scott J. T. Long-term management of gout and hyperuricaemia. Br Med J. 1980 Nov 1;281(6249):1164–1166. doi: 10.1136/bmj.281.6249.1164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Steele T. H. Asymptomatic hyperuricemia: pathogenic or innocent bystander? Arch Intern Med. 1979 Jan;139(1):24–25. doi: 10.1001/archinte.139.1.24a. [DOI] [PubMed] [Google Scholar]
  25. Steele T. H., Rieselbach R. E. The renal mechanism for urate homeostasis in normal man. Am J Med. 1967 Dec;43(6):868–875. doi: 10.1016/0002-9343(67)90245-8. [DOI] [PubMed] [Google Scholar]
  26. Vogler W. R., Drane J. W. Effect of allopurinol on urinary ammonia excretion in patients with gout. Metabolism. 1969 Jun;18(6):519–544. doi: 10.1016/0026-0495(69)90145-0. [DOI] [PubMed] [Google Scholar]
  27. Weinman E. J. Uric acid and the kidney. Perspect Nephrol Hypertens. 1976;3:141–158. [PubMed] [Google Scholar]
  28. Yü T. F., Berger L., Dorph D. J., Smith H. Renal function in gout. V. Factors influencing the renal hemodynamics. Am J Med. 1979 Nov;67(5):766–771. doi: 10.1016/0002-9343(79)90732-0. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES